Product NDC: | 0378-1160 |
Proprietary Name: | Guanfacine |
Non Proprietary Name: | guanfacine Hydrochloride |
Active Ingredient(s): | 1 mg/1 & nbsp; guanfacine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-1160 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074796 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120327 |
Package NDC: | 0378-1160-01 |
Package Description: | 100 TABLET in 1 BOTTLE (0378-1160-01) |
NDC Code | 0378-1160-01 |
Proprietary Name | Guanfacine |
Package Description | 100 TABLET in 1 BOTTLE (0378-1160-01) |
Product NDC | 0378-1160 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | guanfacine Hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120327 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | GUANFACINE HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |